Concepedia

Miriam Schlenk

MS

8

Publications

269

Citations

8

H-Index

2007

Active since

Affiliations

University of Bonn(Current)

UCB Pharma (Belgium)

Freie Universität Berlin

Jagiellonian University

Miriam Schlenk is an author at University of Bonn specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2007–2019

8

Publications

8

Dual Targeting of Adenosine A<sub>2A</sub> Receptors and Monoamine Oxidase B by 4<i>H</i>-3,1-Benzothiazin-4-ones

Anne Stößel, Miriam Schlenk, Sonja Hinz et al. · Journal of Medicinal Chemistry · 2013 · 84 citations · Full text

Benzothiazinones: A Novel Class of Adenosine Receptor Antagonists Structurally Unrelated to Xanthine and Adenine Derivatives

Michael Gütschow, Miriam Schlenk, Jürgen Gäb et al. · Journal of Medicinal Chemistry · 2012 · 57 citations

, , +14

1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases

Pierre Koch, Rhalid Akkari, Andreas Brunschweiger et al. · Bioorganic & Medicinal Chemistry · 2013 · 29 citations · Full text

, , +8

8‐Benzyltetrahydropyrazino[2,1‐<i>f</i>]purinediones: Water‐Soluble Tricyclic Xanthine Derivatives as Multitarget Drugs for Neurodegenerative Diseases

Andreas Brunschweiger, Pierre Koch, Miriam Schlenk et al. · ChemMedChem · 2014 · 26 citations

8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors

Andreas Brunschweiger, Pierre Koch, Miriam Schlenk et al. · Bioorganic & Medicinal Chemistry · 2016 · 23 citations · Full text

, , +5

Rows per page

1–5 of 8